# Baxter completes acquisition of Claris Injectables for $625 million

Baxter International Inc. completed the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company, for approximately $625 million, gaining three manufacturing plants and over 50 products.

- Type: Acquisition
- Announced: 2017-07-27
- Where: India
- Value: $625.0M
- Status: completed
- Products: generic injectable medicines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Baxter International](https://endata.com/companies/20761.md) (acquirer)
- [Claris Injectables Limited](https://endata.com/companies/20762.md) (target)

## Sources

- [baxter.com.pl](https://www.baxter.com.pl/en/baxter-newsroom/baxter-completes-acquisition-claris-injectables-expanding-generic-injectable), 2017-07-27: "Baxter International Inc. today announced the completion of the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company."
- [biopharmadive.com](https://www.biopharmadive.com/news/closing-claris-deal-baxter-set-to-invest-in-three-new-plants/448577/), 2017-08-03: "Claris adds a piece to the puzzle, which is the ability to do the filling operations and packaging, also the procurement of APIs and manufacturing of APIs in a very cost-effective way with good quality product."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.